{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:07:22Z","timestamp":1745640442748,"version":"3.40.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04191-1","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T14:14:05Z","timestamp":1745590445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematopoietic stem cell translation for relapse of psoriasis. Systematic review"],"prefix":"10.1007","volume":"317","author":[{"given":"Wenqiu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"10281","key":"4191_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN, Psoriasis (2021) Lancet 397(10281):1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"issue":"6","key":"4191_CR2","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.3390\/ijms22062979","volume":"22","author":"N Kanda","year":"2021","unstructured":"Kanda N, Psoriasis (2021) Pathogenesis, comorbidities, and therapy updated. Int J Mol Sci 22(6):2979. https:\/\/doi.org\/10.3390\/ijms22062979","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4191_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/bjd.20963","volume":"186","author":"L Puig","year":"2022","unstructured":"Puig L, Costanzo A, Mu\u00f1oz-El\u00edas EJ et al (2022) The biological basis of disease recurrence in psoriasis: a historical perspective and current models. Br J Dermatol 186(5):773\u2013781. https:\/\/doi.org\/10.1111\/bjd.20963","journal-title":"Br J Dermatol"},{"issue":"3","key":"4191_CR4","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.xjidi.2022.100116","volume":"2","author":"D Tian","year":"2022","unstructured":"Tian D, Lai Y (2022) The relapse of psoriasis: mechanisms and mysteries. JID Innov 2(3):100116. https:\/\/doi.org\/10.1016\/j.xjidi.2022.100116","journal-title":"JID Innov"},{"issue":"5","key":"4191_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bjd.20517","volume":"185","author":"SM Lwin","year":"2021","unstructured":"Lwin SM, Snowden JA, Griffiths CEM (2021) The promise and challenges of cell therapy for psoriasis. Br J Dermatol 185(5):887\u2013898. https:\/\/doi.org\/10.1111\/bjd.20517","journal-title":"Br J Dermatol"},{"issue":"1","key":"4191_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","volume":"80","author":"K Balassa","year":"2019","unstructured":"Balassa K, Danby R, Rocha V (2019) Haematopoietic stem cell transplants: principles and indications. Br J Hosp Med (Lond) 80(1):33\u201339. https:\/\/doi.org\/10.12968\/hmed.2019.80.1.33","journal-title":"Br J Hosp Med (Lond)"},{"issue":"7","key":"4191_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41409-022-01702-w","volume":"57","author":"T Alexander","year":"2022","unstructured":"Alexander T, Greco R (2022) Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the autoimmune diseases working party (ADWP) of the European society for blood and marrow transplantation (EBMT). Bone Marrow Transpl 57(7):1055\u20131062. https:\/\/doi.org\/10.1038\/s41409-022-01702-w","journal-title":"Bone Marrow Transpl"},{"key":"4191_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-med-070119-115617","volume":"72","author":"T Alexander","year":"2021","unstructured":"Alexander T, Greco R, Snowden JA (2021) Hematopoietic stem cell transplantation for autoimmune disease. Annu Rev Med 72:215\u2013228. https:\/\/doi.org\/10.1146\/annurev-med-070119-115617","journal-title":"Annu Rev Med"},{"issue":"7","key":"4191_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","volume":"12","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Carubbi F, Liakouli V et al (2013) Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy. Autoimmun Rev 12(7):709\u2013716. https:\/\/doi.org\/10.1016\/j.autrev.2012.10.004","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4191_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","volume":"13","author":"JF Swart","year":"2017","unstructured":"Swart JF, Delemarre EM, van Wijk F et al (2017) Haematopoietic stem cell transplantation for autoimmune diseases. Nat Rev Rheumatol 13(4):244\u2013256. https:\/\/doi.org\/10.1038\/nrrheum.2017.7","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4191_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2141.2012.09070.x","volume":"157","author":"A Holbro","year":"2012","unstructured":"Holbro A, Abinun M, Daikeler T (2012) Management of autoimmune diseases after Haematopoietic stem cell transplantation. Br J Haematol 157(3):281\u2013290. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09070.x","journal-title":"Br J Haematol"},{"issue":"7","key":"4191_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/1574888X14666190429141421","volume":"14","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yu Q, Hu Y, Shi Y (2019) Current research and use of mesenchymal stem cells in the therapy of autoimmune diseases. Curr Stem Cell Res Ther 14(7):579\u2013582. https:\/\/doi.org\/10.2174\/1574888X14666190429141421","journal-title":"Curr Stem Cell Res Ther"},{"key":"4191_CR13","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","volume":"368","author":"M Campbell","year":"2020","unstructured":"Campbell M, McKenzie JE, Sowden A et al (2020) Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 368:l6890. https:\/\/doi.org\/10.1136\/bmj.l6890","journal-title":"BMJ"},{"issue":"6","key":"4191_CR14","doi-asserted-by":"publisher","first-page":"489e","DOI":"10.1016\/j.jtct.2021.03.023","volume":"27","author":"I Shifa","year":"2021","unstructured":"Shifa I, Hazlewood GS, Durand C et al (2021) Efficacy of allogeneic hematopoietic cell transplantation for autoimmune diseases. Transplantation Cell Therapy 27(6):489e. 1-489.e9","journal-title":"Transplantation Cell Therapy"},{"issue":"9","key":"4191_CR15","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/art.1780400923","volume":"40","author":"HM Cooley","year":"1997","unstructured":"Cooley HM, Snowden JA, Grigg AP, Wicks IP (1997) Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthr Rhuem 40(9):1712\u20131715. https:\/\/doi.org\/10.1002\/art.1780400923","journal-title":"Arthr Rhuem"},{"issue":"4","key":"4191_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/ard.2003.010702","volume":"63","author":"M Mohren","year":"2004","unstructured":"Mohren M, Daikeler T, Benz D, G\u00fcnaydin I, Kanz L, K\u00f6tter I (2004) Myeloablative immunosuppressive treatment with autologous Haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance. Ann Rheum Dis 63(4):466\u2013467. https:\/\/doi.org\/10.1136\/ard.2003.010702","journal-title":"Ann Rheum Dis"},{"key":"4191_CR17","unstructured":"Yu Ji, Zhang W, Su H, Xiao X (2008) Hematopoietic stem cell transplantation for autoimmune diseases. In: Cross-Strait Seminar of China Association for Science and Technology (Academic Conference)"},{"issue":"27","key":"4191_CR18","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1200\/JCO.2008.17.6560","volume":"26","author":"F Braiteh","year":"2008","unstructured":"Braiteh F, Hymes SR, Giralt SA, Jones R (2008) Complete remission of psoriasis after autologous hematopoietic Stem-Cell transplantation for multiple myeloma. JCO 26(27):4511\u20134513. https:\/\/doi.org\/10.1200\/JCO.2008.17.6560","journal-title":"JCO"},{"issue":"11","key":"4191_CR19","first-page":"781","volume":"25","author":"H Ding","year":"2008","unstructured":"Ding H (2008) Two cases of autogenous bone marrow transplantation for psoriasis with acute leukemia. J Clin Intern Med 25(11):781","journal-title":"J Clin Intern Med"},{"issue":"1","key":"4191_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1684\/ejd.2016.2893","volume":"27","author":"A Azevedo","year":"2017","unstructured":"Azevedo A, Gon\u00e7alves C, Selores M, Torres T (2017) Remission of psoriasis after autologous stem cell transplantation - until when? Eur J Dermatology 27(1):74\u201375. https:\/\/doi.org\/10.1684\/ejd.2016.2893","journal-title":"Eur J Dermatology"},{"issue":"50","key":"4191_CR21","doi-asserted-by":"publisher","first-page":"e13589","DOI":"10.1097\/MD.0000000000013589","volume":"97","author":"W Chen","year":"2018","unstructured":"Chen W, Ren G, Zuo K, Huang X (2018) Complete remission of both Immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report. Medicine 97(50):e13589. https:\/\/doi.org\/10.1097\/MD.0000000000013589","journal-title":"Medicine"},{"key":"4191_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6215958","volume":"2018","author":"P Kaloyannidis","year":"2018","unstructured":"Kaloyannidis P, Al Shaibani E, Mashhour M et al (2018) De Novo psoriasis vulgaris diagnosed after nivolumab treatment for refractory Hodgkin\u2019s lymphoma, completely resolved after autologous hematopoietic stem cell transplantation. Case Rep Hematol 2018:1\u20134. https:\/\/doi.org\/10.1155\/2018\/6215958","journal-title":"Case Rep Hematol"},{"key":"4191_CR23","unstructured":"Wang M Severe psoriasis completely absent after allogeneic bone marrow transplantation. Foreign Medical Dermatology Register. Published online August 1991:233"},{"key":"4191_CR24","doi-asserted-by":"publisher","unstructured":"Snowden JA, Kearney P, Kearney A et al (1998) Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthr Rhuem 41(3):453\u2013459. https:\/\/doi.org\/10.1002\/1529-0131(199803)41:3%3C453::AID-ART11%3E3.0.CO;2-#","DOI":"10.1002\/1529-0131(199803)41:3%3C453::AID-ART11%3E3.0.CO;2-#"},{"issue":"7","key":"4191_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","volume":"28","author":"S Slavin","year":"2000","unstructured":"Slavin S, Nagler A, Varadi G, Or R (2000) Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 28(7):853\u2013857. https:\/\/doi.org\/10.1016\/S0301-472X(00)00172-7","journal-title":"Exp Hematol"},{"issue":"2","key":"4191_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00007890-200107270-00032","volume":"72","author":"S Chakrabarti","year":"2001","unstructured":"Chakrabarti S, Handa SK, Bryon RJ, Griffiths MJ, Milligan DW, WILL MIXED CHIMERISM CURE AUTOIMMUNE DISEASES AFTER A NONMYELOABLATIVE STEM CELL TRANSPLANT? (2001) Transplantation 72(2):340\u2013342. https:\/\/doi.org\/10.1097\/00007890-200107270-00032","journal-title":"Transplantation"},{"issue":"12","key":"4191_CR27","first-page":"874","volume":"41","author":"J Lou","year":"2002","unstructured":"Lou J, Wang J, Ning F (2002) Allogeneic hematopoietic stem cell transplantation cured psoriasis with acute leukemia: two cases. Chin J Intern Med 41(12):874","journal-title":"Chin J Intern Med"},{"issue":"4","key":"4191_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.bmt.1704146","volume":"32","author":"R Kojima","year":"2003","unstructured":"Kojima R, Kami M, Kim SW et al (2003) Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl 32(4):439\u2013442. https:\/\/doi.org\/10.1038\/sj.bmt.1704146","journal-title":"Bone Marrow Transpl"},{"key":"4191_CR29","unstructured":"He Y ling, Lu X jin, Qiu J yin, Zhu T jun. Severe vulgaris psoriatic patients with acute myelogenous leukaemia and resolution after allogeneic bone marrow transplantation\/peripheral blood stem cell transplantation. Chin Med J (Engl). 2005;118(10):861\u2013865."},{"issue":"5","key":"4191_CR30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/ard.2005.039479","volume":"65","author":"AC Woods","year":"2006","unstructured":"Woods AC (2006) Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic Haematopoietic stem cell transplantation. Ann Rheum Dis 65(5):697\u2013697. https:\/\/doi.org\/10.1136\/ard.2005.039479","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"4191_CR31","first-page":"733","volume":"36","author":"L Sun","year":"2007","unstructured":"Sun L, Sun J, Zeng K, Meng F, Zhou Z, Liu Q (2007) Allogeneic hematopoietic stem cell transplantation for the treatment of refractory psoriasis complicated by chronic myeloid leukemia: 1 case. J Clin Dermatology 36(11):733\u2013734","journal-title":"J Clin Dermatology"},{"key":"4191_CR32","doi-asserted-by":"publisher","unstructured":"Ciurea SO, Hansrivijit P, Ciurea AM et al (2019) Curative potential of hematopoietic stem cell transplantation for advanced psoriasis. Am J Hematol 94(6). https:\/\/doi.org\/10.1002\/ajh.25470","DOI":"10.1002\/ajh.25470"},{"issue":"6","key":"4191_CR33","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.24953\/turkjped.2021.06.017","volume":"63","author":"D G\u00fcler","year":"2021","unstructured":"G\u00fcler D, G\u00fcrel G, Yal\u00e7\u0131n G\u015e et al (2021) A case of pediatric psoriasis achieving remission after allogenic bone marrow transplantation. Turk J Pediatr 63(6):1078\u20131083. https:\/\/doi.org\/10.24953\/turkjped.2021.06.017","journal-title":"Turk J Pediatr"},{"issue":"6","key":"4191_CR34","doi-asserted-by":"publisher","first-page":"489e","DOI":"10.1016\/j.jtct.2021.03.023","volume":"27","author":"I Shifa","year":"2021","unstructured":"Shifa I, Hazlewood GS, Durand C et al (2021) Efficacy of allogeneic hematopoietic cell transplantation for autoimmune diseases. Transpl Cell Ther 27(6):489e. 1-489.e9","journal-title":"Transpl Cell Ther"},{"key":"4191_CR35","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.3389\/fimmu.2018.02602","volume":"9","author":"KCR Malmegrim","year":"2018","unstructured":"Malmegrim KCR, Lima-J\u00fanior JR, Arruda LCM, de Azevedo JTC, de Oliveira GLV, Oliveira MC (2018) Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers. Front Immunol 9:2602. https:\/\/doi.org\/10.3389\/fimmu.2018.02602","journal-title":"Front Immunol"},{"key":"4191_CR36","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3389\/fimmu.2018.02056","volume":"9","author":"A Leyendecker","year":"2018","unstructured":"Leyendecker A, Pinheiro CCG, Amano MT, Bueno DF (2018) The use of human mesenchymal stem cells as therapeutic agents for the in vivo treatment of Immune-Related diseases: A systematic review. Front Immunol 9:2056. https:\/\/doi.org\/10.3389\/fimmu.2018.02056","journal-title":"Front Immunol"},{"key":"4191_CR37","doi-asserted-by":"publisher","first-page":"7061408","DOI":"10.1155\/2019\/7061408","volume":"2019","author":"L Wen","year":"2019","unstructured":"Wen L, Labopin M, Badoglio M, Wang D, Sun L, Farge-Bancel D (2019) Prognostic factors for clinical response in systemic lupus erythematosus patients treated by allogeneic mesenchymal stem cells. Stem Cells Int 2019:7061408. https:\/\/doi.org\/10.1155\/2019\/7061408","journal-title":"Stem Cells Int"},{"key":"4191_CR38","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.2147\/DDDT.S225613","volume":"13","author":"L Wang","year":"2019","unstructured":"Wang L, Huang S, Li S et al (2019) Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: A prospective phase I\/II study. Drug Des Devel Ther 13:4331\u20134340. https:\/\/doi.org\/10.2147\/DDDT.S225613","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"4191_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.295.5.527","volume":"295","author":"RK Burt","year":"2006","unstructured":"Burt RK, Traynor A, Statkute L et al (2006) Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295(5):527\u2013535. https:\/\/doi.org\/10.1001\/jama.295.5.527","journal-title":"JAMA"},{"issue":"1","key":"4191_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/ard.2007.071464","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, Marjanovic Z, van den Hoogen FHJ et al (2008) Long-term follow-up results after autologous Haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 67(1):98\u2013104. https:\/\/doi.org\/10.1136\/ard.2007.071464","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4191_CR41","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","volume":"110","author":"RA Nash","year":"2007","unstructured":"Nash RA, McSweeney PA, Crofford LJ et al (2007) High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 110(4):1388\u20131396. https:\/\/doi.org\/10.1182\/blood-2007-02-072389","journal-title":"Blood"},{"issue":"6","key":"4191_CR42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/sj.bmt.1705782","volume":"40","author":"Y Oyama","year":"2007","unstructured":"Oyama Y, Barr WG, Statkute L et al (2007) Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transpl 40(6):549\u2013555. https:\/\/doi.org\/10.1038\/sj.bmt.1705782","journal-title":"Bone Marrow Transpl"},{"key":"4191_CR43","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3389\/fimmu.2019.01570","volume":"10","author":"R Greco","year":"2019","unstructured":"Greco R, Labopin M, Badoglio M et al (2019) Allogeneic HSCT for autoimmune diseases: A retrospective study from the EBMT ADWP, IEWP, and PDWP working parties. Front Immunol 10:1570. https:\/\/doi.org\/10.3389\/fimmu.2019.01570","journal-title":"Front Immunol"},{"issue":"1","key":"4191_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41423-019-0291-4","volume":"17","author":"L Chen","year":"2020","unstructured":"Chen L, Shen Z (2020) Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders. Cell Mol Immunol 17(1):64\u201375. https:\/\/doi.org\/10.1038\/s41423-019-0291-4","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"4191_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/jid.2010.280","volume":"131","author":"M Su\u00e1rez-Fari\u00f1as","year":"2011","unstructured":"Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Lowes MA, Krueger JG (2011) Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol 131(2):391\u2013400. https:\/\/doi.org\/10.1038\/jid.2010.280","journal-title":"J Invest Dermatol"},{"issue":"4","key":"4191_CR46","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jaci.2018.08.048","volume":"143","author":"I Gallais S\u00e9r\u00e9zal","year":"2019","unstructured":"Gallais S\u00e9r\u00e9zal I, Hoffer E, Ignatov B et al (2019) A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional skin from patients with psoriasis. J Allergy Clin Immunol 143(4):1444\u20131454. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.048","journal-title":"J Allergy Clin Immunol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04191-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T14:14:09Z","timestamp":1745590449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04191-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04191-1","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"740"}}